Skip to main content

ADVERTISEMENT

Piotr Wilkołek, MD, PhD

Original Contribution
02/29/2016
The aim of this first-in-human (FIH) study was to evaluate the efficacy and safety of the novel NovaCross microcatheter system in eligible consecutive patients with chronic total occlusion (CTO).    
The aim of this first-in-human (FIH) study was to evaluate the efficacy and safety of the novel NovaCross microcatheter system in eligible consecutive patients with chronic total occlusion (CTO).    
The aim of this first-in-human...
02/29/2016
Journal of Invasive Cardiology